Auren Rx Review: Seven NAD+ Prices, No State List

Almost every compounded NAD+ seller we have read publishes one number. Auren Rx (aurenrx.com) publishes seven — a separate price for each strength and each bottle size, across an injection, four nasal spray options and two jars of cream, with the milligrams per milliliter and the volume printed beside each one.¹ We read the whole shelf in August 2026. On price disclosure it is the best-built NAD+ surface in this batch of six providers. On one other thing it is the worst, and the two facts sit about four clicks apart.

The seven rungs

These are the no-commitment prices — what you pay if you buy a month and do not subscribe.

Three things are unusual here at once. Strength is stated, volume is stated, and the cream and the spray are not lumped together as "NAD+ topical" and "NAD+ nasal" with a single figure over them. That is the level of detail you need to compare anything, and it is close to absent everywhere else on our NAD+ price index.

The number you will see quoted elsewhere is $30 lower

Every rung above has a subscription price exactly $30 under it: the injection is $179 subscribed, the 30 mL 300 mg/mL spray $219, the 90 g cream $185. Both numbers are real and both are purchasable.

What makes this worth a paragraph is where the lower one ends up. The product pages emit their own machine-readable markup, and the price inside it is the subscribe rung — so any tool that reads structured data instead of the rendered table will record the injection at $179. If you see Auren Rx quoted at $179 somewhere, that is why, and it is not a made-up figure. It is the number for a commitment you may not have agreed to. We file the month-to-month rung throughout, here as everywhere.

What the milligrams buy, and what they do not

Because the strengths are published you can do the arithmetic few rows here let you do. The injection is 1,000 mg of NAD+ for $209. The largest nasal option — 300 mg/mL across 30 mL — is 9,000 mg for $249.

Resist the conclusion that wants to follow. Nine times the material for $40 more is a fact about how these two products are priced, not about how much NAD+ reaches your bloodstream by either route, because nobody has measured that for either route in a person. Cost per milligram is a real comparison only inside a route, and even then only against the same route somewhere else. Our route-by-route breakdown explains why the bioavailability ranking people quote does not survive contact with the outcome data, and the injection dosage calculator will tell you how long a 10 mL vial lasts at a given dose without implying that the dose does anything.

The cream is the rung to be most careful about

$155 for 30 g and $215 for 90 g of a 10% NAD+ cream is a real price for a real product, and it is the one on the menu we would steer a reader away from on chemistry alone.

NAD+ has a molecular weight of about 663 Daltons.² The long-standing rule of thumb in dermal pharmacology is that molecules above roughly 500 Daltons do not cross intact skin in useful amounts by passive diffusion.³ NAD+ is above that ceiling, and it is also charged and water-loving, which is the opposite of the profile that crosses the skin's lipid barrier.⁴ There is no published human study showing that any topical NAD+ product raises blood NAD+. We go through this in detail in what the transdermal evidence actually shows; the short version is that a 10% cream is a well-priced version of the least plausible delivery route on the site.

What the evidence is for the two routes that are plausible

Injection and nasal spray are the rungs most buyers here are choosing between, so it is worth being exact about what stands behind them.

For injected NAD+, there is no randomized human trial and no published pharmacokinetic study. The single human study of administered NAD+ is a pilot in which a small number of people received a six-hour intravenous infusion, and it measured the plasma and urine metabolome rather than any clinical outcome.⁵ Injection is not IV, and even the IV literature stops there. More in the injection evidence file.

For intranasal NAD+, the studies people cite are rodent models of stroke and traumatic brain injury.⁶⁷ They are real experiments and they are not evidence that a spray raises NAD+ in a healthy adult human; the nose-to-brain route in general remains an active research problem rather than a solved delivery method.⁸ See does it absorb through the nose.

What does have controlled human data is the oral precursor nicotinamide riboside, which raises blood NAD+ reliably and dose-dependently.⁹¹⁰ Even there the benefits are the weak part: a systematic review of precursor trials found metabolic effects limited and inconsistent despite the biomarker rising.¹¹ So the honest framing of every rung on this page is that you are paying for a delivery route, not for a result anyone has demonstrated.

What Auren Rx does not tell you

It never publishes the states it serves. Its terms describe services as available to people located in "certain states" and in "a state where we operate", and no list appears anywhere on the site. Every other provider in this batch either names its states or claims all fifty. You find out whether you are eligible by starting an intake, which matters most if you are in a state with restrictive telehealth rules — exactly the reader who most needs to know before handing over a medical history.

The pharmacy is never named individually, described only as Auren RX or one of its partner pharmacies; you may elect a local pharmacy instead, in which case the membership fee excludes the medication. No individual prescriber is named and no NPI is published. Clinical services are attributed to Beluga Health, P.A., a real telehealth professional association. The corporate entity is Hades Capital LLC doing business as Auren RX, with no published address. Product pages show 4.6 to 4.9 star ratings with no review count and no source, so we do not repeat them. Two products are missing from the site's own sitemap.

On fees, the record is better than the disclosure record. The membership fee is charged the day membership commences and is non-refundable once paid — but membership begins after a provider has communicated a care plan and you elect to proceed, so the charge follows clinical review rather than preceding it. Billing is described as approximately every 28 to 30 days, which is slightly short of a calendar month and is disclosed as such. Cancellation is month-to-month, and membership can be paused. There is no prepay tier anywhere, which means there is no prepay figure masquerading as a monthly one — the trap that produces most of the wrong numbers in this category.

The weight-loss line, briefly

Auren Rx also sells compounded semaglutide and tirzepatide, at $199 and $299 a month with no commitment ($169 and $259 subscribed), plus a separately named microdose program. Two notes for anyone comparing: the weight-loss page loads with tirzepatide already selected, so a glance records $299 as "the price"; and the navigation's "from $129/mo" is the microdose semaglutide subscribe rung, $70 under the cheapest standard monthly rung. GLP-1 is not what this site is for, but the same care applies to reading it.

The regulatory screen

The trading name, the legal entity, the medical group and the intake platform all returned zero company-column matches in the FDA's live warning-letter index when we screened them in August 2026.¹² The pass carried a positive control — an unrelated telehealth seller with a letter on the record — which returned correctly, so the clean result is evidence rather than a query that failed quietly.

Where it lands

If you have decided you want compounded NAD+ and you want to know exactly what you are buying before you buy it, Auren Rx tells you more than anyone else in this batch: route, strength, volume, both rungs, no prepay tier, billing cadence labeled honestly. That is a genuinely good disclosure record with one hole punched straight through the middle of it, and the hole is the question you cannot answer from the outside — whether it can legally treat you where you live.

Weigh that against what the product is. Every price on this page buys a route with no human trial behind it, and the cheapest evidence-backed way to raise NAD+ remains an oral precursor at a fraction of any figure here — see is NAD+ therapy worth it and is nicotinamide riboside worth it. For the operators we compare it against, read The Edit's $249 injection with a prescriber you can look up and Pepti's three-route menu and the contradiction sitting inside it. The ranked options we do have a commercial relationship with are on our NAD+ rankings hub, disclosed there.